Cargando…

Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones

The possibility that a single human tumor may be composed of an heterogeneous population of cells with respect to susceptibility to lysis by autologous CTL clones was investigated by testing six cytolytic clones derived by micromanipulation against the autologous metastatic melanoma, Me28, and again...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1986
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188019/
https://www.ncbi.nlm.nih.gov/pubmed/3484513
_version_ 1782146310145572864
collection PubMed
description The possibility that a single human tumor may be composed of an heterogeneous population of cells with respect to susceptibility to lysis by autologous CTL clones was investigated by testing six cytolytic clones derived by micromanipulation against the autologous metastatic melanoma, Me28, and against 31 clones derived from Me28 by cloning in soft agar. Highly significant differences in the lysis of many tumor clones were observed by three of the CTL effectors in comparison with the cytotoxicity achieved on Me28. These results indicate that cloned cellular reagents can detect heterogeneity among cells isolated from the same melanoma, and suggest that the target determinants recognized on the autologous tumor might be differentially expressed on different neoplastic cells.
format Text
id pubmed-2188019
institution National Center for Biotechnology Information
language English
publishDate 1986
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21880192008-04-17 Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones J Exp Med Articles The possibility that a single human tumor may be composed of an heterogeneous population of cells with respect to susceptibility to lysis by autologous CTL clones was investigated by testing six cytolytic clones derived by micromanipulation against the autologous metastatic melanoma, Me28, and against 31 clones derived from Me28 by cloning in soft agar. Highly significant differences in the lysis of many tumor clones were observed by three of the CTL effectors in comparison with the cytotoxicity achieved on Me28. These results indicate that cloned cellular reagents can detect heterogeneity among cells isolated from the same melanoma, and suggest that the target determinants recognized on the autologous tumor might be differentially expressed on different neoplastic cells. The Rockefeller University Press 1986-01-01 /pmc/articles/PMC2188019/ /pubmed/3484513 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones
title Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones
title_full Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones
title_fullStr Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones
title_full_unstemmed Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones
title_short Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones
title_sort heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic t lymphocyte clones
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188019/
https://www.ncbi.nlm.nih.gov/pubmed/3484513